NO20012249D0 - Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat - Google Patents

Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat

Info

Publication number
NO20012249D0
NO20012249D0 NO20012249A NO20012249A NO20012249D0 NO 20012249 D0 NO20012249 D0 NO 20012249D0 NO 20012249 A NO20012249 A NO 20012249A NO 20012249 A NO20012249 A NO 20012249A NO 20012249 D0 NO20012249 D0 NO 20012249D0
Authority
NO
Norway
Prior art keywords
solid composition
preparation
mannitol
cerivastatin
composition containing
Prior art date
Application number
NO20012249A
Other languages
English (en)
Other versions
NO20012249L (no
Inventor
Tomohiro Yoshinari
Fritz Schueckler
Norbert Poellinger
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14109240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20012249(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20012249L publication Critical patent/NO20012249L/no
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20012249D0 publication Critical patent/NO20012249D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/26—Hexahydroxylic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Steroid Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
NO20012249A 1996-04-16 2001-05-07 Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat NO20012249D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9440196 1996-04-16
PCT/JP1997/001286 WO1997038960A1 (en) 1996-04-16 1997-04-14 D-mannitol and its preparation

Publications (2)

Publication Number Publication Date
NO20012249L NO20012249L (no) 1998-12-16
NO20012249D0 true NO20012249D0 (no) 2001-05-07

Family

ID=14109240

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19984803A NO311349B1 (no) 1996-04-16 1998-10-15 D-mannitol og dens fremstilling, samt faststoffsammensetning inneholdende D-mannitol
NO20012249A NO20012249D0 (no) 1996-04-16 2001-05-07 Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19984803A NO311349B1 (no) 1996-04-16 1998-10-15 D-mannitol og dens fremstilling, samt faststoffsammensetning inneholdende D-mannitol

Country Status (27)

Country Link
US (1) US6503918B2 (no)
EP (1) EP0902777B2 (no)
KR (1) KR20000005486A (no)
CN (1) CN1221398A (no)
AT (1) ATE202768T1 (no)
AU (1) AU718658B2 (no)
BG (1) BG63460B1 (no)
BR (1) BR9708672A (no)
CA (1) CA2251092A1 (no)
CU (1) CU22776A3 (no)
CZ (1) CZ333698A3 (no)
DE (1) DE69705516T3 (no)
DK (1) DK0902777T4 (no)
EA (1) EA000968B1 (no)
ES (1) ES2158540T5 (no)
GR (1) GR3036760T3 (no)
HU (1) HUP9902165A3 (no)
ID (1) ID16566A (no)
IL (1) IL126580A (no)
NO (2) NO311349B1 (no)
NZ (1) NZ332313A (no)
PL (1) PL329614A1 (no)
PT (1) PT902777E (no)
SK (1) SK282768B6 (no)
TR (1) TR199802079T2 (no)
TW (1) TW515787B (no)
WO (1) WO1997038960A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008506A1 (de) * 2000-02-24 2001-09-13 Bayer Ag Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
FR2807034B1 (fr) † 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
TWI290053B (en) * 2000-09-19 2007-11-21 Daiichi Seiyaku Co Medicinal composition for preventing the generation of a disagreeable taste
US6979462B1 (en) * 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
BRPI0309894B8 (pt) * 2002-05-14 2021-07-27 Dupont Nutrition Usa Inc composição, processo para preparar uma composição de celulose microcristalina, produto alimentício, composição farmacêutica, composição cosmética, forma de dosagem farmacêutica, e, composição industrial
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
JP5053865B2 (ja) * 2005-12-28 2012-10-24 武田薬品工業株式会社 口腔内崩壊性固形製剤の製造法
JP5255429B2 (ja) 2006-02-20 2013-08-07 中外製薬株式会社 リン酸オセルタミビル含有医薬組成物
EP2076249A2 (en) * 2006-10-27 2009-07-08 FMC Corporation Dry granulation binders, products, and use thereof
CN101646461A (zh) * 2007-03-13 2010-02-10 大日本住友制药株式会社 口腔崩解片
CA2687813C (en) * 2007-05-22 2015-07-07 Ssci, Inc. Preparation of mannitol modification iii
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
US8716536B2 (en) 2010-12-17 2014-05-06 Merck Patent Gmbh Process for the preparation of directly compressible δ-mannitol
US9826763B2 (en) 2011-10-05 2017-11-28 Fmc Corporation Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
EP2764045B1 (en) 2011-10-05 2017-03-01 FMC Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
WO2013085810A2 (en) 2011-12-09 2013-06-13 Fmc Corporation Co-attrited stabilizer composition
KR102501024B1 (ko) * 2014-07-21 2023-02-20 로께뜨프레르 직접 압축에 의한 타정을 위한 당 조성물
IT201900002857A1 (it) 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
CN113116843A (zh) * 2021-05-11 2021-07-16 福建海西新药创制有限公司 一种含有缬沙坦的药物组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
DE3245170A1 (de) 1982-12-07 1984-06-07 Merck Patent Gmbh, 6100 Darmstadt Verbesserter sorbit, verfahren zur herstellung und verwendung
FR2571045B1 (fr) 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
FR2571046B1 (fr) 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
JPH0653658B2 (ja) 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
NO177005C (no) 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
DE69022861T2 (de) 1989-01-24 1996-04-04 Spi Polyols Inc Kryoschützende kristalline Sorbitolkügelchen.
ES2062341T3 (es) 1989-03-29 1994-12-16 Takeda Chemical Industries Ltd Composicion de un compuesto del grupo de la vitamina b, y su produccion.
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
FR2710637B1 (fr) † 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
AUPM411494A0 (en) 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation

Also Published As

Publication number Publication date
IL126580A (en) 2001-08-08
HUP9902165A3 (en) 2001-01-29
EA199800888A1 (ru) 1999-04-29
CU22776A3 (es) 2002-07-24
DK0902777T4 (da) 2004-10-11
IL126580A0 (en) 1999-08-17
CZ333698A3 (cs) 1999-01-13
EP0902777B2 (en) 2004-06-16
NZ332313A (en) 2000-02-28
NO311349B1 (no) 2001-11-19
US20020107420A1 (en) 2002-08-08
EA000968B1 (ru) 2000-08-28
EP0902777B1 (en) 2001-07-04
SK282768B6 (sk) 2002-12-03
ES2158540T3 (es) 2001-09-01
PL329614A1 (en) 1999-03-29
NO984803D0 (no) 1998-10-15
ID16566A (id) 1997-10-16
NO984803L (no) 1998-12-16
US6503918B2 (en) 2003-01-07
AU2522297A (en) 1997-11-07
ATE202768T1 (de) 2001-07-15
DE69705516D1 (de) 2001-08-09
BG63460B1 (bg) 2002-02-28
DE69705516T2 (de) 2002-04-25
SK143298A3 (en) 1999-04-13
BR9708672A (pt) 1999-08-03
WO1997038960A1 (en) 1997-10-23
CA2251092A1 (en) 1997-10-23
DK0902777T3 (da) 2001-09-24
HUP9902165A2 (hu) 1999-11-29
AU718658B2 (en) 2000-04-20
EP0902777A1 (en) 1999-03-24
DE69705516T3 (de) 2004-09-30
PT902777E (pt) 2001-11-30
GR3036760T3 (en) 2001-12-31
NO20012249L (no) 1998-12-16
ES2158540T5 (es) 2004-11-16
TR199802079T2 (xx) 1999-02-22
TW515787B (en) 2003-01-01
CN1221398A (zh) 1999-06-30
BG102818A (en) 1999-05-31
KR20000005486A (ko) 2000-01-25

Similar Documents

Publication Publication Date Title
NO20012249L (no) Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat
IT8922768A0 (it) Composti attivi come inibitori dell'enzima hmg-coa reduttasi
EP0428038A3 (en) Transdermal application of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
BR9805544C1 (pt) Uso de um composto.
ZA975470B (en) Insulin preparations containing naci.
ITMI931306A1 (it) Procedimento microbico per la preparazione di mevinolina
IT1237792B (it) Composti attivi come inibitori dell'enzima hmg-coa reduttasi
NO20033184L (no) Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
ITMI931680A0 (it) Procedimento per la preparazione di alcansolfonammidi
BR9005006A (pt) Composicoes de tipo azeotropico estabilizadas de 1,1-dicloro-2,2,2-trifluoroetano e 1,1-dicloro-1-fluoroetano
NZ326769A (en) High-content famciclovir tablets
ITFI910242A1 (it) Procedimento per la formazione di calzature aperte e calzature cosi' costituite
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
FR2710673B1 (fr) Composition d'enduit de parement.
ITMI911093A1 (it) Composizione farmaceutica contenente un'associazione di 3, 4-di-o isobutirril-epinina ed isosorbide-5- monoidrato
ITRM920498A0 (it) Composizione per l'ignifugazione delle materie polimere.
ITBG910005U1 (it) Dispositivo per l'applicazione rapida di soprattacchi per calzature
ITCT930006V0 (it) "la rubrica dei farmaci di....."
ITUD930250A1 (it) Procedimento di realizzazione di quadretti per foto-ricordo e quadretti per foto-ricordo cosi' ottenuti
NO932528D0 (no) Fremgangsmaate for fremstilling av form 1 renitidinhydroklorid
IT1281325B1 (it) Procedimento per la stabilizzazione e/o il ripristino di strutture inclinate o deformate
FI950981A (fi) Hiirialusta
FI951741A (fi) Hiirialusta

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application